Collaborative R&D Period definition

Collaborative R&D Period means with respect to (i) the Synthetic Enhancing Compound Program the period beginning on the Original Effective Date and concluding on September 30, 2016; (ii) the Natural Enhancing Compound Program and the Natural Sweetener Compound Program, the period beginning on the Original Effective Date and ending September 30, 2019, except that such period may be extended with respect to such programs by PEPSICO’s exercise of the Extension Option in accordance with Section 2.3.
Sample 1Sample 2
Collaborative R&D Period has the meaning set forth in Section 3."
Sample 1Sample 2
Collaborative R&D Period means the period beginning on the Effective Date and ending 36 months thereafter, unless concluded earlier in accordance with Section 15.
Sample 1

Examples of Collaborative R&D Period in a sentence

  • The earliest we could see the transition, which would occur with a five-year average return of 1,000 fish and 750 naturally spawned fish, is 2021, Kline said.

  • Subject to Section 9.5.2, during only the Original Collaborative R&D Period for the Natural Enhancing Compound Program, SENOMYX agrees not to provide research and development services or grant any rights to SENOMYX Technology to a Third Party for use in the discovery or commercialization of Natural Compounds that have an enhancing effect on the sweetness of a Target Sweetener and that are intended for use as a sweetness enhancer in any Exclusive Product Category.

  • If during any year of the Collaborative R&D Period KO is paying royalties, then all royalties up to [***] will be waived.

  • Notwithstanding the foregoing, if during the Original Collaborative R&D Period, PEPSICO sublicensed the rights applicable to a specified Selected Enhancing Compound to a specified Ingredient Supplier, such […***…].

  • Schueler provided a brief update on the Executive & Audit Committee meeting which included approval of the Office of Audit & Risk & Compliance 2021 Final Progress Report, the annual plan and the Enterprise Risk Management Report.

  • Each year during the first four years of the Original Collaborative R&D Period, PEPSICO will pay SENOMYX annual funding as follows: ● […***…] for the Synthetic Enhancing Compound Program ● […***…] for the Natural Sweetener Compound Program; and ● […***…] for the Natural Enhancing Compound Program.

  • Subject to the terms and conditions of this Agreement, SENOMYX hereby grants to PEPSICO and its Affiliates […***…] license under the Target IP for each Selected Synthetic Enhancing Compound selected during the Original Collaborative R&D Period, […***…] Beverages and Beverage Bases that incorporate the applicable Selected Synthetic Enhancing Compound, […***…].

  • Foods That May Not Be Credited as GrainsCertain snack-type foods, such as cheese puffs, popcorn, and potato chips, do not qualify as grains and may not be credited toward meeting the grains requirement in meals served under the CNP.

  • During the Original Collaborative R&D Period, SENOMYX will prepare one Research Plan for the Synthetic Enhancing Compound Program and a second Research Plan for both the Natural Enhancing Compound Program and Natural Sweetener Compound Program and, after review by PEPSICO, such Research Plans will be submitted to the applicable Steering Committee(s) for approval at the first meeting of the Steering Committee (which pursuant to Section 3.5 will take place within thirty days of the Original Effective Date).

  • The Steering Committee will first meet no later than thirty days after the Effective Date and at least four times per year during the Collaborative R&D Period and the Commercialization Period of this Agreement using mutually agreed upon meeting locations and formats including teleconferencing and videoconferencing.

Related to Collaborative R&D Period

  • Research Program Term has the meaning set forth in Section 2.2.

  • Research Period means the research period as described in the Commissioned Research Plan. In accordance with the provisions of this Agreement, in the event that the Agreement ended prior to the completion date of the research originally set, the date the Agreement ends shall be read as the research period.

  • Research Program has the meaning set forth in Section 2.1.

  • Collaboration Term has the meaning specified in Section 2.1.2 hereof.

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Collaboration Know-How means all Know-How and Materials discovered, created, conceived, developed or reduced to practice in the course of performing activities under the Collaboration Program (whether solely by one Party or jointly by the Parties, in each case with their Affiliates or any Third Parties or any employees, consultants or agents of any of the foregoing which perform activities under the Collaboration Program).

  • Development Period means the period from the date of this Agreement until the Appointed Date;

  • Collaboration Product means any pharmaceutical product in finished form that contains a Collaboration Compound, either as the sole active ingredient or in combination with one or more other active ingredients, and all present and future formulations, dosages and dosage forms thereof.

  • Collaboration has the meaning set forth in Section 2.1.

  • Research Term has the meaning set forth in Section 3.2.

  • Promotion Period means the period the Promotion is open, as specified in clause 5.1.

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.

  • Product Candidate means each of MYO-101, MYO-102, MYO-103, MYO-201 and MYO-301, as defined on Exhibit B, in each case in any form or formulation.

  • Program Period means the period of time which the department intends to support the program without requiring the recompetition for funds. The program period is specified within the grant application.

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Research Plan shall have the meaning set forth in Section 2.1.

  • Development Program means the implementation of the development plan.

  • Licensed Compound means [***].

  • Collaboration IP means Collaboration Know-How and Collaboration Patents.

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Research Project means a discrete scientific endeavor to answer a research question or a set of research questions related to medical marijuana and is required for a medical marijuana research license.